Rakesh Jhunjhunwala-backed Concord Biotech Files Draft Papers For IPO; Check Details
Rakesh Jhunjhunwala-backed Concord Biotech has filed preliminary papers with markets regulator Sebi to issue its initial public offering (IPO). It will be entirely an offer for sale of (OFS) of 2,09,25,652 equity shares by Helix Investment…